×
×
×
Learn more about Mass Cytometry
Jump to videos
Fluidigm Mass Cytometry Videos
Search
Webinars and Seminars
CyTOF Summit on demand - Igniting Insight into Immuno-Oncology | 14 Jun 2022
In this first installment of the CyTOF Summit, Standard BioTools™ brought together investigators from academia, pharma and biot...
Jun-28-2022
Cutting Edge Cytometry and Clinical Trials: A Case Study | Caroline Roe, MLI
Roe shares her approach to high-parameter immune monitoring panel design, as well as the planning and execution of clinical cor...
May-20-2022
Method validation studies using the Maxpar® Direct™ Immune Profiling Assay™ | Sasidhar Vemula, PhD
Vemula details the validation process for two Maxpar panels offered by Labcorp: the Maxpar Direct Immune Profiling Assay and th...
May-20-2022
Efficient, High-Content Immune Profiling with CyTOF® XT and MDIPA | Vinicius Motta, PhD
Motta describes how fully automated flow cytometry with CyTOF XT™ combined with the deep immune profiling provided by the Maxpa...
May-19-2022
Single-Cell Immune Profiling Can Help Resolve Tumor Microenvironment Complexities | GEN
Speakers: Katie Vowell, PhD , Principal Investigator – Immunology, GlaxoSmithKline Florence Perrin Patel, PhD, Investigator, G...
Apr-04-2022
Sample Multiplexing in Suspension Mass Cytometry with Easy Cell Barcoding
Speakers: Connie Inlay, PhD, Senior Field Applications Specialist, Fluidigm Anita Kant, PhD, Senior Field Applications Special...
Mar-29-2022
Introducing CyTOF® XT and Maxpar™ Direct™ Assays for efficient high-content immune profiling
Emily Thrash, Field Application Scientist for Mass Cytometry at Fluidigm, introduces CyTOF® XT, the most technologically advanc...
Feb-16-2022
Mass Cytometry for Precision Medicine | Petter Brodin, MD, PhD
Petter Brodin, MD, PhD, discusses how he is implementing the new, high-throughput CyTOF® XT high-dimensional cytometer to advan...
Feb-08-2022
Leveraging CyTOF to track cancer vaccine induced T cell responses for up to 20 years | Erika Crosby
Long-term tracking of vaccine-elicited tumor antigen-specific T cell responses in cancer patients using CyTOF technology. A cr...
Nov-10-2021
Profiling three layers of human immunity with CyTOF®, Olink® and automated RNA-seq
Part of our Scientist in the Spotlight series: Date: 8 December, 2020 To understand why a particular immune response occurs th...
Nov-05-2021
←
Previous
1
2
3
4
5
6
Next
→